Stock & Company Details
Galmed Pharmaceuticals Ltd $GLMD
Price:
N/A
N/A
1M
$4.5M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.01
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GLMD technical indicators
Latest Galmed Pharmaceuticals Ltd (GLMD) indicator readings as of 2026-08-28.
GLMD's 14-day RSI is 79.2, in overbought territory. At $4.17 it is trading 397.6% above its 200-day moving average of $0.84, and above its 50-day average of $1.17. Price sits in the middle of its Bollinger Bands ($-1.64 to $5.80). ADX reads 45.6, indicating a trending market.
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Galmed Pharmaceuticals Ltd. is a clinical stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. Its lead compound, Aramchol™, a backbone drug candidate for the treatment of NASH and fibrosis is currently in a Phase 3 registrational study.It is also collaborating with the Hebrew University in the development of Amilo-5MER, a 5 amino acid synthetic peptide and plan to initiate a first in human study by the first quarter of 2021.
Finance Bot
Ask your questions
Start by typing a question below.
